| 发明名称 |
HCV Combination Therapies Comprising Pegylated Interferon, Ribavirin and Telaprevir |
| 摘要 |
The invention relates to combination therapies for the treatment of hepatitis C virus with telaprevir and pegylated interferon alfa-2a with or without ribavirin. The invention relates to the treatment of patients with bridging fibrosis infected with HCV using the combination therapy. |
| 申请公布号 |
US2012039850(A1) |
申请公布日期 |
2012.02.16 |
| 申请号 |
US201113207773 |
申请日期 |
2011.08.11 |
| 申请人 |
MCNAIR LINDSAY;KAUFFMAN ROBERT S.;ALAM JOHN J.;POLO RAMON;PICCHIO GASTON RAFAEL;BEUMONT MARIA GLORIA;JANSSEN PHARMACEUTICA NV;VERTEX PHARMACEUTICALS INCORPORATED |
发明人 |
MCNAIR LINDSAY;KAUFFMAN ROBERT S.;ALAM JOHN J.;POLO RAMON;PICCHIO GASTON RAFAEL;BEUMONT MARIA GLORIA |
| 分类号 |
A61K38/21;A61P31/14 |
主分类号 |
A61K38/21 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
